AzTrials
AzTrials

Critical IllnessNCT03268967

Optimized Admission to the Intensive Care Unit by Using Crisis Resource Management (CRM)

A study testing Structured admission procedure in people with Critical Illness, run by Hillerod Hospital, Denmark at 1 site in Denmark.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Admission to the intensive care unit (ICU) is vital for surviving critical illness. An admission to ICU without having a consistent structure, structured review of the patient and a solid team organization lead to unclear communication and responsibility. Read more about this study

Who is it for?
Any age
Conditions the study is for
Critical Illness
What is being tested?
Structured admission procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
1,800 participants
Where
1 siteDenmark
Study dates
1 Apr 2014to 31 Dec 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • ICU admissions

Who cannot join

  • None
  • Drop-out are deaths

Trial locations and contacts

1 site in 1 country.

Denmark1 site
  • Department of Anaestesiology

    Holbæk, 4300

Other trials in Denmark

About this study

Admission to the intensive care unit (ICU) is vital for surviving critical illness. An admission to ICU without having a consistent structure, structured review of the patient and a solid team organization lead to unclear communication and responsibility. Factors that correlate with patient acceptance and safety, morbidity and mortality. The hypothesize was that a structured admission can improve patients safety, reduce delays in treatment, reduce ICU length of stay, and improve mortality rate. The overall objective was to optimize patient safety, and effectively use available resources to reduce admission time, delays in treatment and procedures and mortality by using both quantitative and qualitative methods.

Read the detailed description

The quantitative before-data is a one-year observational period prior to the intervention measured by different perspectives; patients and staff outcomes.

After the intervention, was qualititive data collected from participants, who received simulation training.

The quantitative after-data is a one-year observational period post-intervention with same outcomes as before starting the intervention.

Data is already collected registry data from hospital quality assurance board. Data will be compared before and after with assessor blinded analysis. Missing data will not be replaced but reported as missing.

The investigators will try to compare the results with data from an approximately comparative ICU in Denmark due to the implementation of a new patient management system called the Health Portal.

The statistical analysis plan is based on descriptive and comparative analyses of the group before and after the trial. The quantitative results are explained in in-depths description from participants.

Being tested
Structured admission procedure
Keywords
intensive care, crisis resource management, simulation training, before and after study
Medical subject headings
Critical Illness

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Structured admission procedureBehavioural

    Also called Standard Care

    A structured ICU admission was inspired by principles of Crisis Resource Management and simulation training of ICU staff members. The Principles of Crisis Resource Management consisted of a treatment manual, a learning video, clear precise communication tool based on Identification-Situation-Background-Analysis-Recommendations (ISBAR) and Closed loop, actions cards, and ABCDE-evaluation of the patient including debriefing, and training in the simulation environment.

Study groups in NCT03268967
Study groupRoleWhat they receive
Structured Admission procedureActive comparatorAfter implementation of a structured admission procedure to all ICU patients inspired by principles of Crisis Resource Management, Closed loop communication, action cards, and staff simulation training
Receives: Behavioral: Structured admission procedure
Standard CareNo interventionRandomly admission procedure to all ICU patients based on the clinicians' evaluation prior implementation of the intervention.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. ICU length of stay (LOS)

    Days admitted at the ICU using registre data

    Measured: through study completion, an average of 1 year

Secondary outcomes (8)
  1. Hospital length of stay (LOS)

    Days admitted to the hospital using registre data

    Measured: At Hospital discharge within one-year before and after the intervention implementation

  2. Line Sepsis

    Treatment package of number of the line sepsis after ICU admission covering the number of patients with line sepsis using registre data on Lactat <1 hour, bacteria samples ≤1 hour taken, time between diagnosis of sepsis and taken bacteria samples, time between diagnosis and given antibiotics measured by registre data

    Measured: through study completion, an average of 1 year

  3. Ventilated associated pneumonia (VAP)

    Number of VAP measured by registre data

    Measured: through study completion, an average of 1 year

  4. Re-intubations

    Number of re-intubations measured by registre data

    Measured: through study completion, an average of 1 year

  5. 30-days Mortality

    30-days mortality rates after ICU discharge measured by registre data

    Measured: 30 days through study completion, an average of 1 year

  6. 90-days Mortality

    90-days mortality rates after ICU discharge measured by registre data

    Measured: 90 days through study completion, an average of 1 year

  7. Staff turn-over

    Staff turn-over before and after the intervention measured by registre data

    Measured: through study completion, an average of 1 year

  8. Sick Leave

    Sick leave amongst staff members measured by registre data

    Measured: through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2017
  2. Study start1 Apr 2014
  3. Primary completion1 Oct 2017
  4. Study completion31 Dec 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Sequential
Model description
Before and after interventional study
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
1,800 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03268967
Sponsor's protocol ID
113581
Other IDs
113581
Status last verified
Mar 2018
First submitted
28 Aug 2017
Last updated
9 Mar 2018
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

A study testing Structured admission procedure in people with Critical Illness, run by Hillerod Hospital, Denmark at 1 site in Denmark.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

ICU length of stay (LOS) (time frame: through study completion, an average of 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT03268967 | AzTrials